CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,226 enrolled
Drug / intervention
Etanerceptdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04267614
NCT04267614N/ACompleted
CompareCT.gov

Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Rheumatoid Arthritis With Etanercept

Pfizer·observational·Posted Feb 13, 2020·Updated Jul 7, 2023

In Brief

An observational study evaluating Etanercept for Arthritis Rheumatoid. Completed, enrolled 1,226 participants across 1 site.

Detailed Summary

This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis Rheumatoid
CountriesIraq
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 13, 2020
Enrollment StartNov 1, 2018
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.4 years ago

Interventions

Etanerceptdrug

Patients who received etanercept for RA